• BX Home
  • Multiple Sclerosis: News [Page 25]

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

MULTIPLE SCLEROSIS

Multiple sclerosis (MS) is an autoimmune condition that attacks the central nervous system. This topic tracks information on multiple sclerosis treatments and the financial impact on companies researching and developing new drugs to fight this terrible disease.

Multiple Sclerosis is part of Business Exchange, suggested by Steve McCarthy. This topic contains 967 news and 242 blog items. Read updated news, blogs, and resources about Multiple Sclerosis. Find user-submitted articles and reactions on Multiple Sclerosis from like-minded professionals.

News

Please add new articles to this topic

TV Wendy Denning's husband may be struck off over ��6,000 stem cell ja...more

health expert Wendy Denning faces being struck off the medical register after a ruling that he exploited vulnerable...

MS death case trio bailed againmore

Farncombe MS death inquiry bailed again Three people arrested in connection with the death of a woman with multiple...

Formatech Donates Manufacturing Services to Produce Experimental Drug ...more

Please choose from the options below: If the difficulties persist, you may wish to send a message to the Help Desk.

Biogen CEO Mullen's Total 2009 Compensation Valued At $10.4 Millionmore

comes as the company has faced pressure from activist shareholders and concern about the growth trajectory of...

Novartis' New CEO Makes Bold Promisesmore

mid-single digit sales growth this year. One drug he seems particularly excited about is his company���s experimental...

Mayo Clinic Research Provides New Insight into Tissue Damage in Multip...more

Please choose from the options below: If the difficulties persist, you may wish to send a message to the Help Desk.

Keep It Up and They'll Make You Chairmanmore

integrating eye-care specialist Alcon (NYSE: ACL) Novartis also has a couple of upcoming drug approvals, including an...

Will the Drugs Ever Work for Elan?more

our coverage here .] Shareholders have seen Elan through accounting difficulties that slammed the share price, rejoiced...

Drug Sales May Advance to $1.1 Trillion on Emerging-Market Boommore

$125 billion in health care. The top disease areas for growth will be in diabetes, cancer, HIV, and multiple sclerosis,...

Elan considers splitting company into two entitiesmore

by former chief executive Donal Geaney. Most of the company?s pipeline in areas such as Alzheimer?s disease and...

UPDATE 1-Elan mulls spinning off drug development unitmore

on-going capital requirements for utilization against a broad array of potential opportunities,' it said.

New York an Insurance Lab on Skyrocketing Ratesmore

premiums, April Welles was able to buy her own plan and still be covered for her cancer and multiple sclerosis.

New York Offers Costly Lessons on Insurancemore

premiums, April Welles was able to buy her own plan and still be covered for her cancer and multiple sclerosis.

Diet targets chronic diseasesmore

diets have long been recommended for heart disease, weight loss, depression, acne, anti-aging, arthritis, Crohn's...

Biogen: Total PML Cases At 46, Deaths At 11 As Of April 6more

NEW YORK (Dow Jones)--Biogen Idec Inc. (BIIB) disclosed four more cases of a rare brain infection in multiple sclerosis...

UPDATE 2-Genzyme moves to strengthen defenses against Icahnmore

arguments. While Genzyme mainly makes products for rare and chronic diseases, the company has an experimental drug for...

Avanir Says Neurological Drug Safe And Tolerable in Testingmore

AVNR) said the new low-dose version of neurological disorder pill Zenvia was safe and tolerable by patients with...

MS patient has ‘energy to burn’ after new proceduremore

and rarely uses his wheelchair – a much different picture from just a few months ago. Diagnosed with multiple sclerosis...

Teva Gets Less Genericmore

new to Teva. The drugmaker has branded drugs in the respiratory and women's health spaces, and its multiple sclerosis...

Biogen Races to Create Test for Brain Disease Linked to MS Drugmore

April 9 (Bloomberg) -- Biogen Idec Inc. wants to take the fear out of prescribing its multiple sclerosis treatment...

Review confirms PTSD, other syndromes in Gulf vetsmore

and deaths from car accidents. Inadequate evidence could be found of links to cancer, blood disease, hormone...

UPDATE 1-Merck KGaA says sees EU statement on MS pill in Q3more

soon as possible. Novartis on Feb. 22 won U.S. priority review status for its oral treatment for multiple sclerosis.

FDA Warns Biogen On Tysabri, Gilead On Truvada Promotionsmore

WASHINGTON (Dow Jones)--The Food and Drug Administration said Wednesday a promotional webcast involving the multiple...

After Google-Apple, Can Biogen Directors Sit on Genzyme Board?more

Also, Genzyme and Biogen are heading toward increased competition in coming years based on Genzyme’s efforts in...

14 Biotech Stocks Facing FDA Approvalmore

post to the agency's web site on May 4 or May 5. Novartis(NVS) Drug/indication: Gilenia for multiple sclerosis Approval...

Top Sources: Multiple Sclerosis

  • St. Petersburg Times
  • Reuters
  • Chicago Tribune
  • Mail Online UK
  • MarketWatch
  • BBC
  • Boston Globe
  • Philadelphia Inquirer
  • BusinessWeek
  • Seattle Times

Most Active Users in this Topic

see all contributors in Multiple Sclerosis

Featured White Papers

Post a Job

Jobs in this Topic

Director Specialty Distribution Multiple Sclerosis Genzyme | Cambridge, MA
Posted: Mar 29
RN/Registered Nurse Clinical Coordinator - Ambulatory Mulitple Sclerosis Center Rush University Medical Center | Chicago, IL
Posted: May 14
Academic Multiple Sclerosis Opening in Midwest Jordan Medical Consultants | Springfield, IL
Posted: May 18
Multiple Sclerosis Nurse Educator Quintiles Transnational | Lansing, MI
Posted: May 20
Neurology - Multiple Sclerosis Physician Practicewisemd | Cincinnati, OH
Posted: Mar 30

Report comment contains invalid characters. ()
cancel
Search Cancel